Post-Prandial Liver Glucose Metabolism in PCOS — PLUM  

Obesity Clinical Trial

Official title: Post-Prandial Liver Glucose Metabolism in Polycystic Ovarian Syndrome (PCOS) and Understanding Standard of Care Medications

Status Completed

Clinical Trial Summary

The Investigators will measure if hepatic metabolism is upregulated in obese girls with PCOS and hepatic steatosis (HS), compared to PCOS without HS and obese controls without HS.

Clinical Trial Description

This will be a cross-sectional study with 4 groups of youth. A 6 hour OSTT (Oral Sugar Tolerance Test) with an oral U-C13 glycerol tracer will be paired with nuclear magnetic resonance spectroscopy (NMR) isotopomer analysis of serum samples to describe flux through the hepatic pentose phosphate pathway, TCA cycle and FAS pathways in girls with PCOS receiving lifestyle only, metformin or oral contraceptive treatment, and obese girls with regular menses receiving lifestyle therapy. Hepatic steatosis will be measured with MRI.

Please note that 3 study groups: PCOS on metformin, PCOS on oral contraceptive treatment, and obese girls with regular menses were not funded in the study, so no participants were enrolled in these 3 arms of the study. ;

Related Conditions & MeSH terms

• Fatty Liver
• Hepatic Steatosis
• Obesity
• Polycystic Ovarian Syndrome
• Polycystic Ovary Syndrome
• Syndrome

• NCT number: NCT03041129
• Study type: Observational
• Source: University of Colorado, Denver
• Status: Completed
• Start date: April 14, 2017
• Completion date: September 29, 2018